Skip to main content

Table 4 Plasma concentrations of carotenoids, tocopherols and retinoids following portfolio and control diets

From: Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds

Variable

Intensive portfolio

Routine portfolio

Control

 

Wk 0

Wk 12a

Wk 24a

Wk 0

Wk 12a

Wk 24a

Wk 0

Wk 12a

Wk 24a

 

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

α-tocopherol b

47.72

2.51

45.60

2.71

45.23*

2.55

50.15

2.37

47.36*

2.77

47.50

2.83

51.05

2.71

51.76

2.99

49.72

3.05

γ-tocopherol b

4.97

0.22

4.76

0.29

4.71

0.29

5.28

0.30

5.10

0.35

4.99

0.36

4.96

0.30

5.22

0.37

5.21

0.35

Lycopene b

2.61

0.13

2.49

0.23

2.49

0.13

2.78

0.20

2.53

0.17

2.56

0.17

3.21

0.20

3.23

0.17

3.06

0.23

Lutein b

1.65

0.19

1.51

0.21

1.64

0.21

1.80

0.17

1.67

0.16

1.80

0.18

1.71

0.15

1.77

0.18

1.69

0.19

β-carotene b

2.24

0.19

2.07†

0.18

2.06*†

0.19

2.27

0.17

2.11*†

0.17

2.20†

0.17

2.23

0.18

2.38

0.18

2.45

0.17

Retinol b

2.78

0.12

2.65

0.16

2.65*

0.15

2.94

0.15

2.88

0.13

2.83

0.15

2.73

0.12

2.86

0.15

2.84

0.19

α-tocopherol:TC c

7.46

0.46

8.39*

0.51

8.00

0.49

7.91

0.46

8.41

0.55

8.25

0.49

8.07

0.53

8.54

0.53

8.04

0.51

γ-tocopherol:TC c

0.79

0.04

0.88

0.05

0.81

0.05

0.80

0.05

0.91*

0.07

0.88*

0.07

0.81

0.06

0.86

0.06

0.83

0.05

Lycopene:TC c

0.42

0.02

0.45

0.04

0.44

0.02

0.42

0.04

0.44

0.03

0.45

0.03

0.50

0.04

0.54

0.03

0.49

0.04

Lutein:TC c

0.29

0.04

0.29

0.04

0.30

0.04

0.29

0.03

0.31

0.03

0.32

0.03

0.28

0.03

0.29

0.03

0.28

0.03

β-carotene:TC c

0.35

0.04

0.38

0.03

0.37

0.04

0.36

0.03

0.38

0.03

0.38

0.03

0.35

0.03

0.40*

0.03

0.39

0.03

Retinol:TC c

0.43

0.02

0.49*

0.03

0.47

0.03

0.47

0.03

0.52

0.03

0.50

0.03

0.43

0.02

0.47

0.03

0.46

0.03

  1. *Indicates significance compared to respective baseline. †indicates significance with changes from baseline compared to control at respective time point.
  2. aUsing analysis of covariance with sex, treatment and sex by treatment interaction as main effects and baseline as a covariate. A Tukey adjustment was made for multiple comparisons. bμmol/L. cμmol/L:mmol/L.